BiltRx Compounded Tirzepatide
US telehealth platform dispensing compounded tirzepatide at $129 per month through licensed 503A pharmacies.
Get a tirzepatide prescription online through licensed telehealth providers. We compare BiltRx and Arc-1 on cost, consultation process and pharmacy credentials.
US telehealth platform dispensing compounded tirzepatide at $129 per month through licensed 503A pharmacies.
We look for a batch-level certificate of analysis published by the merchant.
Purity percentage and milligrams per vial as stated on the product page.
Clear research-use labeling, lot numbers and storage instructions.
Vials compared on price per milligram, not on sticker price.
US telehealth platform dispensing compounded tirzepatide at $129 per month through licensed 503A pharmacies.

Dose-tiered compounded tirzepatide with glycine and B12 from $199.99 per month, free consultation and free shipping included.
| Product | Monthly | Rx | Pharmacy | Form | Price |
|---|---|---|---|---|---|
| BiltRx BiltRx Compounded Tirzepatide | $129 | Required | US 503A | Injectable | $129/mo |
| Arc-1 Arc-1 Compounded Tirzepatide + Glycine + B | - | Required | - | - | From $199.99 |
Getting a tirzepatide prescription online takes three steps: complete a health intake form, consult with a licensed provider by telehealth, and receive the medication by mail from a US compounding pharmacy. Two platforms we verified handle the entire process digitally. BiltRx charges $129 per month for compounded tirzepatide; Arc-1 starts at $199.99. Both require a real medical evaluation and a licensed prescriber on the other end.
An online tirzepatide prescription follows the same clinical standard as an in-person visit. The delivery method is telehealth, but the prescribing authority, the pharmacy licensing and the regulatory requirements are identical. What changes is convenience: no office visit, no waiting room, and the medication ships to your address.
You create an account on the telehealth platform and fill out a medical intake questionnaire. This covers your current weight, height, BMI, medical history, active medications, allergies and relevant conditions (diabetes, thyroid disease, pancreatitis history, pregnancy). The form also screens for contraindications listed on the FDA label for tirzepatide, including a family history of medullary thyroid carcinoma or MEN2.
A licensed medical provider reviews your intake. At BiltRx, the provider is a US-licensed clinician working through their telehealth platform. At Arc-1, board-certified physicians in their network handle the review. If tirzepatide is clinically appropriate, the provider writes the prescription and sets the starting dose. You do not choose your own dose. If the provider determines tirzepatide is not right for you, they communicate that decision and may recommend alternatives.
The prescription goes to a US-licensed 503A compounding pharmacy. The pharmacy prepares tirzepatide in injectable form at the prescribed concentration. BiltRx and Arc-1 both use 503A pharmacies. Arc-1's formulation includes glycine and B12 alongside tirzepatide. Medication ships in temperature-controlled packaging.
We evaluated both providers on the same criteria: prescriber licensing, pharmacy credentials, LegitScript certification and pricing transparency. Both passed. The differences are in pricing structure, formulation and geographic coverage.
BiltRx charges $129 per month for compounded tirzepatide. The consultation fee and shipping are billed separately; exact amounts are not published on the product page. After completing the intake, a BiltRx provider reviews your case and prescribes if appropriate. The platform also offers brand-name Mounjaro and Zepbound for patients who want or need the FDA-approved version. Those list at $1,499 per month.
Arc-1's process starts with checkout on their website, followed by an online medical intake form. A licensed provider reviews the intake at no charge. If approved, the medication ships with free expedited delivery. Arc-1 offers three dose tiers: 2.5 mg ($199.99), 5 mg ($249.99), and 7.5 mg ($399.99). The formulation adds glycine and B12 to tirzepatide. Arc-1 does not serve California, Arkansas, Indiana, Minnesota or South Carolina.
| Item | BiltRx | Arc-1 (2.5 mg) | Arc-1 (5 mg) | Arc-1 (7.5 mg) |
|---|---|---|---|---|
| Monthly medication | $129 | $199.99 | $249.99 | $399.99 |
| Consultation | Extra | $0 | $0 | $0 |
| Shipping | Extra | $0 | $0 | $0 |
| 12-month medication total | $1,548 | $2,399.88 | $2,999.88 | $4,799.88 |
BiltRx's flat-rate pricing makes it the lowest published medication cost at any dose. The unknown consultation and shipping fees narrow the gap, particularly at the 2.5 mg tier where Arc-1's all-inclusive price is $199.99. At higher doses, BiltRx's advantage increases because its price does not change with dose escalation. Use our cost calculator to project your annual spend with estimated extras.
Telehealth prescribing laws and compounding pharmacy shipping rules vary by state. This affects which providers can serve you.
| State Consideration | BiltRx | Arc-1 |
|---|---|---|
| General availability | Varies by state (list not published) | 45 states + DC |
| Restricted states | Not disclosed | CA, AR, IN, MN, SC |
| How to check | Contact support or start intake | Listed on product page |
If you live in one of Arc-1's restricted states, BiltRx is your compounded option or you can pursue a brand-name prescription through a local physician and retail pharmacy. Our clinics and pharmacies guide covers all three routes.
The intake form takes about 10-15 minutes. Provider review time varies. Arc-1 states that after approval, medication ships via expedited delivery. BiltRx does not publish turnaround times. Most patients receive their first shipment within one to two weeks of starting the process.
Yes. Tirzepatide treatment typically starts at a lower dose and increases gradually. Your prescribing provider determines the schedule based on your response, side effects and weight loss progress. Neither platform publishes a fixed escalation protocol because dosing is individualized.
If the provider determines tirzepatide is not clinically appropriate for you, they will communicate that decision. Reasons for denial may include contraindicated conditions (MTC or MEN2 family history, active pancreatitis, pregnancy), insufficient BMI, or medication interactions. Some providers suggest alternative GLP-1 treatments in those cases.
Compounded tirzepatide prescriptions are typically filled by the provider's partner 503A pharmacy and cannot be transferred to a retail chain like CVS or Walgreens. Those pharmacies dispense only FDA-approved Zepbound or Mounjaro. If you want to fill at a local pharmacy, you need a separate brand-name prescription from a provider who works with retail pharmacies.

Prices, sizes and ratings side by side, updated when the merchant pages change.
Get Tirzepatide